Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement Seite 1

MILAN, N.Y., Feb. 07, 2023 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene
therapy for cancer, has entered into a…